Verseon has unveiled transformative blockchain technology for tokenised securities, developed by its wholly owned subsidiary, BlockRules Ltd. Since its founding in 2002, Verseon aims to develop disruptive technologies and products that advance global health. As part of this, the company is challenging traditional drug development funding models through the process of tokenisation of securities.
BlockRules technology supports the sale, launch, and trading of securities on a public blockchain complete with multi-jurisdictional regulatory compliance integrated and enforced directly on the blockchain. This breakthrough permits fully regulated, secure, and transparent support of securities, including decentralised trading.
Current blockchain technology has the potential to transform the global investment landscape. To accomplish that, token offerings need to comply with existing security regulations if they are to become ubiquitous. The technology developed by BlockRules is designed to overcome these regulatory hurdles.
BlockRules Ltd. plans to offer its technology to innovative companies ready to embrace the rapidly developing blockchain community. By bringing regulatory certainty to the blockchain, BlockRules aims to provide the global investment community with safer and more relevant opportunities for investment.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
